• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CNO Financial Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    2/12/25 4:35:17 PM ET
    $CNO
    Accident &Health Insurance
    Finance
    Get the next $CNO alert in real time by email
    cno-20250212
    0001224608falsetrue00012246082025-02-122025-02-120001224608us-gaap:CommonStockMember2025-02-122025-02-120001224608cno:RightsToPurchaseSeriesEJuniorParticipatingPreferredStockMember2025-02-122025-02-120001224608cno:A5125SubordinatedDebenturesDue2060Member2025-02-122025-02-12


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): February 12, 2025

    CNO Financial Group, Inc.
    (Exact Name of Registrant as Specified in Charter)
     
    Delaware001-3179275-3108137
    (State or Other
    Jurisdiction of Incorporation)
    (Commission File Number)(I.R.S. Employer
    Identification No.)
    11229 Illinois Street
    Carmel, Indiana  46032
    (Address of Principal Executive Offices) (Zip Code)

    (317) 817-6100
    (Registrant's telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.01 per shareCNONew York Stock Exchange
    Rights to purchase Series E Junior Participating Preferred StockNew York Stock Exchange
    5.125% Subordinated Debentures due 2060CNOpANew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 7.01.Regulation FD Disclosure.

    On February 12, 2025, CNO Financial Group, Inc. (the "Company") issued a press release to announce that its Board of Directors: (i) approved an additional $500 million to repurchase the Company's outstanding common stock; and (ii) declared a quarterly dividend of 16 cents per common share payable on March 24, 2025, to shareholders of record at the close of business on March 10, 2025. A copy of the Company's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.

    The information in this Item 7.01, including the Exhibit 99.1 furnished under Item 9.01, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Furthermore, the information in this Item 7.01, including the Exhibit 99.1 furnished under Item 9.01, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

    Item 9.01(d).Financial Statements and Exhibits.

    The following materials are furnished as exhibits to this Current Report on Form 8-K:

    99.1
    Press release of CNO Financial Group Inc. dated February 12, 2025.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).



    2




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    CNO Financial Group, Inc.
    Date: February 12, 2025
    By:
    /s/ Paul H. McDonough
    Paul H. McDonough
    Executive Vice President and
    Chief Financial Officer




    3
    Get the next $CNO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNO

    DatePrice TargetRatingAnalyst
    1/23/2025$38.00Market Perform
    BMO Capital Markets
    4/16/2024$29.00Neutral → Overweight
    Piper Sandler
    1/4/2024$24.00 → $26.00In-line → Underperform
    Evercore ISI
    6/29/2023Mkt Perform
    Raymond James
    9/13/2022$25.00Outperform
    RBC Capital Mkts
    1/26/2022$25.00Hold
    Jefferies
    1/7/2022$27.00 → $28.00Equal-Weight
    Morgan Stanley
    1/5/2022$29.00 → $27.00Overweight → Neutral
    Piper Sandler
    More analyst ratings